Table 5 Interaction effects between patient status (hyperthyroid and euthyroid states) and BAT status (BAT positive and BAT negative).
Hyperthyroid | Euthyroid | Patients status effects | BAT status effects | Interaction | |||
|---|---|---|---|---|---|---|---|
BAT-positive | BAT-negative | BAT-positive | BAT-negative | P values | |||
SUVmax (g/mL) | 2.4 ± 0.3 | 1.3 ± 0.1 | 2.1 ± 0.4 | 1.8 ± 0.3 | 0.71 | 0.008 | 0.28 |
SUVmean (g/mL) | 1.2 ± 0.1 | 0.7 ± 0.1 | 0.9 ± 0.1 | 0.8 ± 0.1 | 0.52 | 0.007 | 0.03 |
sFF (%) | 68.1 ± 1.5 | 74.9 ± 1.8 | 72.7 ± 1.1 | 79.3 ± 1.9 | < 0.0001 | 0.01 | 0.90 |
Alanine | 285.7 ± 23.5 | 323.9 ± 16.9 | 284.6 ± 24.4 | 361.3 ± 16.0 | 0.13 | 0.04 | 0.11 |
Aspartic acid | 19.0 ± 1.9 | 23.5 ± 3.1 | 17.2 ± 1.7 | 24.9 ± 2.3 | 0.93 | 0.06 | 0.50 |
Glutamic acid | 100.7 ± 8.0 | 114.6 ± 10.1 | 82.5 ± 10.0 | 114.2 ± 10.6 | 0.25 | 0.09 | 0.27 |
Isoleucine | 55.2 ± 3.7 | 57.4 ± 4.5 | 44.5 ± 2.8 | 56.5 ± 4.2 | 0.13 | 0.17 | 0.19 |
Leucine | 114.6 ± 6.8 | 118.6 ± 6.6 | 90.0 ± 4.9 | 114.4 ± 6.7 | 0.01 | 0.10 | 0.06 |
Valine | 246.8 ± 11.7 | 239.5 ± 12.4 | 193.0 ± 11.6 | 226.3 ± 13.2 | 0.003 | 0.43 | 0.05 |
Phenylalanine | 63.3 ± 3.6 | 66.2 ± 2.8 | 54.7 ± 2.0 | 66.1 ± 2.5 | 0.08 | 0.05 | 0.08 |
Total AA | 1714.0 ± 80.0 | 1804.0 ± 69.0 | 1557.0 ± 45.4 | 1836.7 ± 75.5 | 0.30 | 0.05 | 0.12 |
BCAA | 416.6 ± 20.6 | 415.5 ± 22.5 | 327.6 ± 18.2 | 397.2 ± 23.6 | 0.007 | 0.24 | 0.06 |